Brand name: Olanzapine (Terry White Chemists)
Olanzapine (Terry White Chemists) is a medicine containing the active ingredient(s) olanzapine. On this page you will find out more about Olanzapine (Terry White Chemists), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: olanzapine
Over 65 years of age?
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Olanzapine (Terry White Chemists) 10 mg film-coated tablet, 28
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
- Treatment of schizophrenia and related psychoses;. - Short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar I disorder;. - Preventing recurrence of manic, mixed or depressive episodes in bipolar I disorder.
Table of characteristics
| Active ingredient | |
|---|---|
| Visual appearance |
White, round, biconvex film-coated tablet. Engraved "APO" on,one side, "OLA" over "10" on the other side.
Images are the copyright of the Pharmacy Guild of Australia |
| Dosage Form | Tablet, film coated |
| Route of administration | Oral |
| Medicine schedule |
28: Prescription Only Medicine, or Prescription Animal Remedy
|
There is one type of pack available.
Pack type 1
| Type | Blister Pack |
|---|---|
| Storage temperature | Store below 25 degrees Celsius |
| Storage conditions | Protect from Moisture |
| Life time | 24 Months |
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 April 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Need more information?
These trusted information partners have more on this topic.
Found 30 results
Terry White Chemists Olanzapine Tablets - myDr.com.au
Terry White Chemists Olanzapine Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Terry White Chemists Citalopram Tablets - myDr.com.au
Terry White Chemists Citalopram Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Olanzapine AN Tablets - myDr.com.au
Olanzapine AN Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Olanzapine-DRLA Tablets - myDr.com.au
Olanzapine-DRLA Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
APO-Olanzapine Tablets - myDr.com.au
APO-Olanzapine Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Chemmart Olanzapine Tablets - myDr.com.au
Chemmart Olanzapine Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Olanzapine ODT-DRLA Orally disintegrating tablets - myDr.com.au
Olanzapine ODT-DRLA Orally disintegrating tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Olanzapine RBX Tablets - myDr.com.au
Olanzapine RBX Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Olanzapine AN ODT Orally disintegrating tablets - myDr.com.au
Olanzapine AN ODT Orally disintegrating tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
APO-Olanzapine ODT Orally disintegrating tablets - myDr.com.au
APO-Olanzapine ODT Orally disintegrating tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 3 results
Clozapine versus other atypical antipsychotics for schizophrenia | Cochrane
This review compared the clinical effects of clozapine with the other atypical antipsychotics. Twenty-seven studies fulfilled the review's criteria and provided data to compare clozapine with antipsychotics such as olanzapine, quetiapine, risperidone, ziprasidone and zotepine. Clozapine was somewhat more efficacious than zotepine. Also, inefficacy of treatment led more frequently to leaving the studies early in the risperidone group suggesting a certain higher efficacy of clozapine. The principal drawback of clozapine were its adverse effects which lead to significantly higher numbers of participants leaving the studies early compared to olanzapine and risperidone. Clozapine was associated with more sedation and hypersalivation than olanzapine, quetiapine and risperidone and with more seizures than olanzapine and risperidone. There was a higher incidence of white blood cell decrease in clozapine groups than olanzapine and more weight gain than in risperidone groups. On the other hand clozapine produced fewer movement disorder than risperidone and less prolactin increase than olanzapine, quetiapine and zotepine.
Read more on Cochrane (Australasian Centre) website
Dealing with drug-seeking behaviour | Issue 3 | Volume 39 | Australian Prescriber
People who misuse prescription drugs most commonly seek prescriptions for opioids and benzodiazepines. Other...
Read more on Australian Prescriber website
Drug diversion | Issue 5 | Volume 38 | Australian Prescriber
Prescription drug diversion has significant health, legal and social implications. Deaths from misuse of prescription drugs account for a significant...
Read more on Australian Prescriber website
